1. Home
  2. GO vs AMPH Comparison

GO vs AMPH Comparison

Compare GO & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grocery Outlet Holding Corp.

GO

Grocery Outlet Holding Corp.

HOLD

Current Price

$11.28

Market Cap

1.3B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.34

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GO
AMPH
Founded
1946
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
GO
AMPH
Price
$11.28
$27.34
Analyst Decision
Hold
Buy
Analyst Count
10
6
Target Price
$15.70
$35.17
AVG Volume (30 Days)
3.1M
455.9K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$4,571,346,000.00
$723,305,000.00
Revenue This Year
$11.29
$0.74
Revenue Next Year
$5.65
$5.63
P/E Ratio
N/A
$12.21
Revenue Growth
7.22
N/A
52 Week Low
$10.21
$20.39
52 Week High
$20.88
$46.11

Technical Indicators

Market Signals
Indicator
GO
AMPH
Relative Strength Index (RSI) 38.90 58.94
Support Level $10.21 $24.92
Resistance Level $11.13 $27.83
Average True Range (ATR) 0.41 1.02
MACD 0.15 0.18
Stochastic Oscillator 68.91 58.33

Price Performance

Historical Comparison
GO
AMPH

About GO Grocery Outlet Holding Corp.

Grocery Outlet Holding Corp is a grocery store operator in the United States. It is a retailer of quality, name-brand consumables and fresh products sold through a network of independently operated stores. The stores are run by Entrepreneurial independent operators which create a neighborhood feel through personalized customer service and a localized product offering.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: